Mass-drug administration curbs scabies for asylum seekers in the Netherlands

May 17, 2018, Public Library of Science

In a new article published in PLOS Neglected Tropical Diseases, Sofanne J. Ravensbergen of the University of Groningen, and colleagues, found that a scabies intervention program (SIP) was effective in reducing the severity of scabies when introduced to the newly arrived Eritrean and Ethiopian asylum seekers who volunteered to take part in the program.

Scabies, a skin infestation caused by the tiny mite Sarcoptes scabiei burrowing into the outer layer of skin, is a major risk factor in the development of bacterial skin infections, relentless itching, and rashes. Nurses and physicians working at national receptions centers in the Netherlands noticed the Eritrean and Ethiopian were particularly affected by scabies. In response, the Dutch national reception centers introduced a SIP for these seekers from January 2014 to March 2016. The authors of this study found that, before the SIP was initiated, 12.3% of 462 asylum seekers developed complications of scabies. Once the SIP was launched, only 4.6% of 897 asylum seekers showed signs of scabies complications.

The researchers were unable to determine how long these volunteer asylum seekers stayed in the asylum centers that implemented the SIP, which made it impossible to calculate the exact incidence rate of scabies. Additionally, since asylum seekers frequently relocate to other asylum centers without a SIP, reinfestations could occur through contact with untreated contagious individuals. However, the number of scabies reinfestations after treatment and the number of complicated forms of scabies were both reduced after introduction of the program.

"Controlling scabies amongst asylum seekers is important to reduce the risk of complicated cases and to prevent the spread of scabies amongst asylum seekers at asylum centres in the Netherlands," notes the authors, "The centralized health care system for asylum seekers that is used in the Netherlands allows accurate follow up of asylum seekers and provides unique retrospective data on the programme."

Explore further: Got scabies? Here's what to do

More information: Beeres DT, Ravensbergen SJ, Heidema A, Cornish D, Vonk M, et al. (2018) Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: A retrospective cohort study between January 2014 - March 2016. PLOS Neglected Tropical Diseases 12(5): e0006401. doi.org/10.1371/journal.pntd.0006401

Related Stories

Got scabies? Here's what to do

December 9, 2017
(HealthDay)—If you or a family member develops scabies, you need to take immediate action, a dermatologist advises.

Study finds specialist support is lacking for LGBT asylum seekers

November 7, 2014
Lesbian, gay, bisexual and transgender (LGBT) asylum seekers – including those living with HIV – face a lack of specialist support and services in the UK, according to a study by the University of Liverpool.

Failed child asylum claims in the UK

June 5, 2014
Research from the University raises concerns that many young people who are refused asylum in the UK are not being advised appropriately and are not appealing against decisions even when they have an arguable case.

Recommended for you

Researchers seek vaccine for 'traveler's diarrhea'

September 25, 2018
Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ...

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

New findings on the muscle disease Laing early-onset distal myopathy

September 24, 2018
New avenues are now being opened toward treatment of Laing distal myopathy, a rare disorder that causes atrophy of the muscles in the feet, hands and elsewhere. In a study published in the journal PNAS, researchers have identified ...

Insulin shows great potential against chronic colitis

September 24, 2018
Diabetes is not the only disease on which insulin has an effect, it appears. In a new study using tests on mice, researchers from the University of Copenhagen, among others, have discovered a new method for treating chronic ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.